Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182868 · ClinicalTrials.gov registry record · NA
Vestibular Testing: Consistency and Effects Over Time
A NA study of Dizziness, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT03182868: Completed NA study of Dizziness, sponsored by University of Miami.
NCT03182868 is a NA study of Dizziness that has completed, run by University of Miami. The registered enrollment target is 78 participants, below the 10,094-participant average among 8 other Dizziness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03182868, a NA study of Dizziness, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test the consistency and repeatability of a portable goggle system for testing optokinetic, ocular, and reaction time. The study examines the day to day consistency, time of day and learning effects as well as any secondary motion sickness.
Primary Outcome
Repeatability, variation and learning effect of vestibular testing of PAS goggles will be evaluated using the test results on both sessions for the following sub-tests: a) Visual Reactive Time (VRT), b) Saccades and Reaction Time (SRT) Saccade Latency, c) SRT Motor Latency, and d) Auditory Reaction Time (ART). ART, VRT and SRT subtests are all evaluated in msec.
Conditions Studied
Interventions
- DEVICE PAS Goggle
Study Locations (1)
Florida
- University of Miami Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2015-10-29 |
| Est. Completion | 2016-11-28 |
| Phase | NA |
What the finished NCT03182868 record still lists
NCT03182868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 10,094-participant average among 8 other Dizziness trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Dizziness appearing as the primary indexed condition, and to 1 intervention - of which PAS Goggle is the first listed.
NCT03182868 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03182868 about?
NCT03182868 is a clinical study titled "Vestibular Testing: Consistency and Effects Over Time". The goal of this study is to test the consistency and repeatability of a portable goggle system for testing optokinetic, ocular, and reaction time. The study examines the day to day consistency, time of day and learning effects as well as any secondary motion sickness.
What is the current status of trial NCT03182868?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2015-10-29. Estimated completion is 2016-11-28.
What conditions does trial NCT03182868 study?
This clinical trial studies the following conditions: Dizziness.
What interventions are being tested in trial NCT03182868?
The interventions under investigation include: PAS Goggle (DEVICE).
Who is sponsoring clinical trial NCT03182868?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03182868 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dizziness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03182868's enrollment target sits among peer trials
78 5th of 8 higher than 4 of 8 other Dizziness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dizziness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
RECRUITING · NA
-
Reducing Vertigo Associated With MRI Machines
RECRUITING · NA
-
Implementation of Evidence-Based Practice for Dizziness
ACTIVE NOT RECRUITING · NA
-
Gaze and Postural Stability in Multiple Sclerosis
COMPLETED · NA
-
"Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI